Effects of Hypertension and Obesity on the Sympathetic Activation of Heart Failure Patients

Hypertension

Volumn 42, Issue 5, 2003, Pages 873-877

  Grassi, Guido ^b   Seravalle, Gino ^b   Quarti Trevano, Fosca ^b   Dell'Oro, Raffaella ^b   Bolla, Gianbattista ^b   Mancia, Giuseppe ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b NONE

Author keywords

Autonomic nervous system; Baroreceptors; Congestive heart failure; Hypertension, essential; Obesity; Sympathetic nervous system

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NEUROENDOCRINE DISEASE; OBESITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RISK ASSESSMENT; SYMPATHETIC NERVE; SYMPATHETIC REFLEX; SYMPATHETIC TONE;

BLOOD PRESSURE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUSCLES; NOREPINEPHRINE; OBESITY; PRESSORECEPTORS; SYMPATHETIC NERVOUS SYSTEM;

EID: 0242693955     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000098660.26184.63     Document Type: Article

References (27)

1. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S, for the SOLVD Investigators. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82: 1724-1729.
2. Benedict CR, Johnstone DE, Weiner DH, Bourassa MG, Bittner V, Kay R, Kirlin P, Greenberg B, Kohn RM, Nickals JM, McIntire K, Quinones MA, Yusuf S. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the registry of Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1994;23: 1410-1420.
3. Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathefic outflow in patients with heart failure. Circulation. 1986;73: 913-919.
4. Hasking GJ, Esler MD, Jennings LL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986; 73:615-621.
5. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, Del Bo A, Sala C, Bolla GB, Pozzi M, Mancia G. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation. 1995;92:3206-3211.
6. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
7. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the Consensus Trial Study Group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation. 1990;82:1730-1736.
8. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences oh high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995;26:1257-1263.
9. Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S, for the SOLVD Investigators. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation. 1996;94:690-697.
10. Esler M, Lambert G, Jennings G. Increased regional sympathetic nervous system activity in human hypertension: causes and consequences. J Hypertens. 1990;8(suppl 7):S53-S57.
11. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G. Sympathetic activation in obese normotensive subjects. Hypertension. 1995;25:560-563.
12. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive humans subjects. Circulation. 1997;96:3423-3429.
13. Grassi G, Seravalle G, Dell'Oro R, Turri C, Bolla GB, Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension. 2000;36:538-542.
14. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension. 1988;14:1277-1283.
15. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension. 1998;31:68-72.
16. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens. 1999;17:1719-1734.
17. Schiller NB, Shah PM, Crawford M, De Maria A, Devereux R. Feigenbaum H, Gutgesell H, Reicheck N, Sahn D. Recommendations for quantitation of left ventricle by two dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358-367.
18. Grassi G, Bolla GB, Seravalle G, Turri C, Lanfranchi A, Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci. 1997;92: 285-289.
19. Grassi G, Seravalle G, Bertinieri G, Turri C, Stella ML, Scopelliti F, Mancia G. Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. Clin Sci. 2001;101:141-146.
20. Zimmerman BG, Sybertz EJ, Wong PC. Interactions between sympathetic and renin-angiotensin system. J Hypertens. 1984;2:581-587.
21. Grassi G. Renin-angiotensin sympathetic crosstalks in hypertension: reappraising the relevance of peripheral interactions. J Hypertens. 2001;19: 1713-1716.
22. Lage SG, Polak JF, O'Leary DH, Creager MA. Relationship of arterial compliance to baroreflex function in hypertensive patients. Am J Physiol. 1993;265:H232-H237.
23. Wolk R, Somers VK. Cardiovascular consequences of obstructive sleep apnea. Clin Chest Med. 2003;24:195-205.
24. Narkiewicz K, van de Borne PJH, Montano N, Dyken M, Phillips BG, Somers VK. The contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation. 1998;97:943-945.
25. Grassi G. Role of the sympathetic nervous system in human hypertension. J Hypertens. 1998;16:1979-1987.
26. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension. J Hypertens. 2001;19:523-528.
27. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol Rev. 1990;70:963-985.